BioSyent Inc. (TSXV:RX)

BioSyent Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	136	128	108	85	104	101
Market Cap Growth	14.58%	17.76%	28.05%	-18.50%	2.59%	22.26%
Enterprise Value	116	112	80	58	78	79
Last Close Price	12.04	10.86	8.94	6.65	7.80	7.47
PE Ratio	16.96	17.56	16.79	15.52	16.54	26.69
Forward PE	14.95	14.52	17.23	13.86	18.77	21.67
PS Ratio	3.43	3.65	3.43	3.03	3.63	4.54
PB Ratio	3.60	3.65	3.12	2.54	3.29	3.78
P/TBV Ratio	4.12	4.24	3.21	2.62	3.38	3.92
P/FCF Ratio	11.38	14.80	21.71	17.28	22.64	14.72
P/OCF Ratio	11.32	14.74	21.45	17.11	22.23	14.69
EV/Sales Ratio	2.94	3.19	2.55	2.09	2.74	3.55
EV/EBITDA Ratio	10.26	11.64	10.54	8.03	9.26	14.78
EV/EBIT Ratio	10.84	12.17	10.76	8.36	9.58	15.77
EV/FCF Ratio	9.75	12.94	16.10	11.90	17.08	11.53
Debt / Equity Ratio	0.03	0.03	0.04	0.04	0.05	0.06
Debt / EBITDA Ratio	0.08	0.11	0.16	0.19	0.18	0.31
Debt / FCF Ratio	0.08	0.12	0.24	0.28	0.34	0.25
Asset Turnover	0.93	0.85	0.77	0.72	0.81	0.69
Inventory Turnover	1.58	1.28	1.15	1.50	2.80	2.33
Quick Ratio	5.00	3.49	5.36	5.63	7.49	5.33
Current Ratio	6.07	4.53	6.48	6.49	8.24	5.79
Return on Equity (ROE)	22.62%	20.84%	18.97%	16.82%	21.53%	14.43%
Return on Assets (ROA)	15.75%	13.85%	11.39%	11.24%	14.46%	9.74%
Return on Capital (ROIC)	17.82%	15.94%	13.20%	12.86%	16.60%	11.20%
Return on Capital Employed (ROCE)	27.80%	25.50%	20.80%	20.10%	24.80%	17.70%
Earnings Yield	6.09%	5.69%	5.96%	6.44%	6.04%	3.75%
FCF Yield	8.79%	6.76%	4.61%	5.79%	4.42%	6.79%
Dividend Yield	1.67%	1.66%	1.79%	0.60%	-	-
Payout Ratio	26.16%	28.61%	29.61%	8.87%	-	-
Buyback Yield / Dilution	2.47%	2.98%	2.95%	2.57%	1.70%	6.10%
Total Shareholder Return	4.14%	4.64%	4.74%	3.17%	1.70%	6.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.